DaVita Venture Group
Corporate venture arm of DaVita investing in kidney care innovation across digital health, care models, pharma, devices, and adjacent clinical services.
DAYLI Partners
Seoul-based Korean VC specializing in bio-healthcare and fintech, managing 47 funds with ~₩685B cumulative AUM across 123 portfolio companies.
DC Global Ventures
Cross-border US-China life-sciences investor (formerly Decheng Capital), $2.5B AUM since 2012, backing biopharma and diagnostics early-to-growth.
DCI Partners
Daiwa Securities' life-science VC arm, evolved from NIF Ventures, running Japan's largest biotech funds bridging Japanese and Taiwanese biotech ecosystems.
DCVC
Deeptech VC backing entrepreneurs solving trillion-dollar problems
Decheng Capital
Global life sciences VC with $2.5B+ AUM backing early-stage biotech and growth-stage healthcare companies across the US and China since 2012.
Deep Insight
Herzliya-based stage-agnostic VC and Israel's first fund dedicated exclusively to deep tech, spanning semiconductors, robotics, photonics, quantum, bio convergence, and advanced materials.
Deep Track Capital
Greenwich-based life sciences crossover fund investing in public equities and pre-IPO biotechnology companies, with $5B+ AUM and a fundamentally driven research approach.
DeepCore
SoftBank-owned Tokyo incubator and VC for AI/deep-tech founders, running the KERNEL community alongside University of Tokyo's Matsuo Lab.
DeepIE Ventures
Ireland-based early-stage VC investing globally in deep science and technology startups from university spin-out through pre-seed and seed rounds.
DeepTech & Climate Fonds (DTCF)
A public venture fund investing in deep tech and climate tech companies across Germany.
DeepWork Capital
Orlando-based early-stage VC investing in tech and life sciences startups across underserved US regions, primarily Florida, at seed and Series A stages.
Deerfield Management
Investment firm dedicated to advancing healthcare through investment, intelligence, and philanthropy.
Define Ventures
Silicon Valley-based digital health VC with $800M AUM across 6 funds, backing early-stage health tech companies from incubation through Series B.
Delos Capital
We empower life sciences leaders to turn bold ideas into medical breakthroughs
Delphinus Venture Capital
Danish evergreen VC investing pre-seed to Series B in deep tech across food, health, defence, and energy; EUR 80M fund, Aarhus-based.
Deming Center Venture Fund
Graduate-student-run fund giving CU Boulder MBA, law, and engineering students hands-on VC experience by investing real capital in Colorado startups.
Denali Growth Partners
Boston growth-equity firm backing founder-led healthcare and tech companies, closing its second $400M fund on the strength of lowering care costs.
Deviation Capital
Early-stage firm backing technical founders at Seed and Series A in AI, robotics, biotech, and data infrastructure; spun out from Two Sigma as Deviation Capital in May 2026.
DFJ Growth
Growth-stage investor partnering with visionary founders
DG Daiwa Ventures
Tokyo VC formed in 2016 as a joint venture between Digital Garage and Daiwa Securities, backing next-gen AI, robotics and fintech startups in Japan and abroad.
Digitalis Ventures
New York-based VC investing in biotechnology, digital health, and animal health companies, combining deep scientific and technical expertise to engineer solutions to unmet health needs.
Dimension
Multi-stage VC with $850M backing companies at the intersection of life sciences and compute — drug discovery AI, lab infrastructure, and biotech software platforms.
Divergent Capital
Pre-seed fund led by Katie Shea and Lucy Wang, using an Atoms/Bits/Cells framework to back deep-tech founders modernizing essential systems.
Showing 169–192 of 709 investors
Get the Complete BioTech Investor Database
709 investors · Stages · Sectors · Locations · CSV + Excel
Get all 709 investors →